CANCER – 2021

日期: 四月 25, 2021


主要议题:

This meeting will serve as a valuable forum for the presentation
and discussion of newly available data across various
 malignancies including all cancers.
 Participants will be provided with updates on practice-changing data
 in a practical and interactive format, fostering discussion,
 and impacting clinical outcomes for patients.

程序:

天 1 – Optimising Clinical Development in Oncology

    • Targeted therapies in clinical development; antibody, vaccines & cell-based therapies
  • Overcoming the mechanisms of cancer drug resistance
  • Co-development of combined oncology therapies
  • Identifying appropriate clinical endpoints
  • Strategies to reach critical go/no-go decisions earlier
  • Novel technologies for imaging in drug development
  • Pharmacovigilance & patient safety
  • Integrating biomarkers in clinical development & trials

天 2 – Operational Challenges of Oncology Clinical Trials

    • Establishing the correct trial population; emerging markets, global trials
  • Adaptive clinical trial design
  • Appropriate site selection
  • Regulatory considerations
  • Clinical trial management
  • Patient recruitment and retention strategies
  • Successfully maintaining CRO relationships
  • Effective use of clinical data & eClinical solutions

Call for abstracts

Deadline for submission: 10/09/2020

The late abstract should contain newly achieved scientific work and results. The abstract has to be one full page (size A4, 210 x 297 mm) plus 1 到 3 explanatory pages with more detailed information about the work.
The abstract written in English and single spaced should include:

  • Applicable topic
  • Full title
  • Full name, affiliation, 地址, phone/fax/e-mail of one author for all correspondence
  • For all other co-authors, full name, affiliation and e-mail
  • Short introductive summary (大约. 1,000 人物) for publication in the Programme Planner
  • Purpose of the work
  • Approach
  • Scientific innovation and relevance
  • Results and Conclusions

For questions concerning abstracts, please contact:

Ms. Kristina Zadorina head_office@nbscience.com

head_office@nbscience.com

The attendees of this event will get a chance to take part in:

  • master class on modern instrumental methods of diagnostics of rheumatic diseases- ultrasounds, 核磁共振成像, osseo densitometry.
  • master class on increasing effective drug treatment of patients with rheumatic diseases.

参与者的参与条件:

注册套餐 包括 参与证书 (英语) ,参加科学会议s, 会议资料, 参观展览并 10-30% 酒店住宿折扣.

需网上报名,未经报名确认不得入场.

NB科学

(deadline – November 01, 2020)

联系 NBScience

教育/会议部:

head_office@nbscience.com

药理

干细胞疗法